Regeneron Pharmaceuticals said Friday it has paused a clinical study of its antibody drug to treat some of the sickest COVID-19 patients because of a potential safety concern.
COVID-19:
News
Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients
By The Hill
| October 30, 2020
Most Popular
#1
Fact check: Hospitals get paid more if patients listed as COVID-19, on ventilators
Sen. Scott Jensen, R-Minn., a physician in Minnesota, was interviewed by "The Ingraham Angle" host Laura Ingraham on April 8 on Fox News and claimed hospitals get paid more if Medicare patients are...
Read More #2
Doctors begin to crack COVID's mysterious long-term effects
Nearly a year into the global coronavirus pandemic, scientists, doctors and patients are beginning to unlock a puzzling phenomenon: For many patients, including young ones who never required...
Read More #3
Alzheimer's research looks at hot spots across the U.S.
With the latest report out this week, scientists and medical researchers are increasingly examining the role of location in prevalence of the disease.
Read More #4
4 Ethical Dilemmas for Healthcare Organizations During the COVID-19 Pandemic
There has already been rationing of testing in the United States and rationing of critical care resources is likely if severely ill COVID-19 patients surge significantly. ...
Read More #5
ECMO Life Support 'Last-Ditch' Intervention for Coronavirus Patients
Extracorporeal membrane oxygenation provides life support for coronavirus patients suffering respiratory failure. ...
Read More